12:57 PM ET
Form 4
Insider Selling
UroGen Pharma CFO Chris Degnan Sells $80.8K of Stock
Chris Degnan, CFO, sold 2,202 shares of UroGen Pharma Ltd. at $36.69 a share, worth $80.8K in total on Oct 8, 2026. Shares held after the trade: 4,561 (-32.6%).
- Value
- $80.8K
- Shares
- 2,202
- Price
- $36.69
- Role
- CFO
- Holding change
- -32.6%
- Trade date
- Oct 8, 2026